clinical trial · NCT06336629
A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne
Acne VulgarisWinlevi (clascoterone) 1% & Duac gel
brief summary
Winlevi is the first topical anti androgen and sebum inhibitor approved for acne vulgaris. There is no study assessing Winlevi in combination treatment for acne .Therefore this study assesses Winlevi with Duac gel in combination to emulate real life practice.
started
Nov 15, 2023
primary completion
Jul 10, 2024
completion
Jul 10, 2024
last updated
Jul 17, 2025
official title
Combination Treatment of Winlevi With Duac Gel in Patients With Acne Vulgaris
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol